News
Leerink Partnrs has cut its Q3 2025 earnings estimate for Regeneron Pharmaceuticals, citing lowered expectations across the ...
REGN | Complete Regeneron Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Bristol-Myers Squibb stock saw a modest bump to $47.55 despite analysts waving caution flags. Short- and long-term technical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results